National UK-wide musculoskeletal surgeon platform MSK Doctors has released a new report, evaluating Arthrosamid (Polyacrylamide PAAG hydrogel) and its efficacy as a treatment for those with knee osteoarthritis and similar conditions.
-- MSK Doctors looks to clarify Arthrosamid’s potential as a pain management solution for knee osteoarthritis patients with its new report. The document explores the medicine’s effects when administered via injection - pointing to promising regenerative and augmentative results.
For more information see https://mskdoctors.com/treatments/arthrosamid
As explained in MSK Doctors’ recent piece, Arthrosamid’s popularity continues to grow in medical settings. It lists a variety of case studies in support, highlighting the impact that the innovative hydrogel had for patients from high-level athletes to younger and older individuals alike - with MSK Doctors noting the improvements they experienced following treatment.
Specifically, its report stresses that Arthrosamid has been found to add stability to the synovial membrane - layers of tissue surrounding knee joints and tendons. The result in many cases was reduced pain and improved mobility, largely stemming from the extra support provided. Most crucially, the treatment has been associated with zero negative side effects, says MSK Doctors.
“With a favourable safety profile and promising patient-reported outcome measures (PROMs), Arthrosamid is gaining traction in the medical community,” says the new MSK Doctors report. “The hydrogel serves as a scaffold for the synovial membrane - offering mechanical support and potentially aiding in the regeneration of damaged tissue.”
Additional effects observed by featured studies include a reduction in bone marrow lesions after one injection. As such, Arthrosamid is becoming notable as a viable and safe treatment for several conditions associated with short and long-term knee pain - news that will come as a relief for sufferers, suggests MSK Doctors.
Most prominently, the report focuses on Arthrosamid’s implications for knee osteoarthritis - an issue that afflicts around 13% of women over 60. MSK Doctors positions the hydrogel as a substantive means of achieving less stiffness and improved function for such patients, together with its aforementioned impact on pain.
The report also estimates that pain reduction and other positive effects can last for up to two years or more. Effectiveness will be contingent on the severity of one’s condition, which is why MSK Doctors urges patients to consult with informed doctors and clinicians on the subject. Its national UK network allows visitors to do so, connecting prospective patients with musculoskeletal specialists stationed in London and across the country.
Interested parties can find further details about MSK Doctors at: https://mskdoctors.com/
Contact Info:
Name: Bethan Lee
Email: Send Email
Organization: MSK Doctors
Address: MSK House London Road Silk Willoughby, Sleaford, Lincolnshire, Sleaford, England NG34 8NY, United Kingdom
Website: https://www.mskdoctors.com
Source: PressCable
Release ID: 89152530
In the event of detecting errors, concerns, or irregularities in the content shared in this press release that require attention or if there is a need for a press release takedown, we kindly request that you inform us promptly by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will promptly address your feedback within 8 hours and take necessary actions to resolve any identified issues diligently or guide you through the removal process. Providing accurate and dependable information is our utmost priority.
